Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine.
Leuk Lymphoma
; 63(3): 729-737, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34738857
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ribonucleotide Reductases
/
Myelodysplastic Syndromes
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Leuk Lymphoma
Year:
2022
Document type:
Article